Bank of America’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-67,923
| Closed | -$846K | – | 7553 |
|
|
2016
Q4 | $846K | Sell |
67,923
-52,655
| -44% | -$634K | ﹤0.01% | 4468 |
|
|
2016
Q3 | $1.65M | Sell |
120,578
-26,067
| -18% | -$262K | ﹤0.01% | 3789 |
|
|
2016
Q2 | $1.08M | Buy |
146,645
+29,363
| +25% | +$220K | ﹤0.01% | 4117 |
|
|
2016
Q1 | $749K | Sell |
117,282
-25,004
| -18% | -$140K | ﹤0.01% | 4315 |
|
|
2015
Q4 | $889K | Buy |
142,286
+122,083
| +604% | +$801K | ﹤0.01% | 4441 |
|
|
2015
Q3 | $118K | Sell |
20,203
-123,121
| -86% | -$949K | ﹤0.01% | 5602 |
|
|
2015
Q2 | $1.19M | Buy |
143,324
+117,085
| +446% | +$1.04M | ﹤0.01% | 3958 |
|
|
2015
Q1 | $216K | Sell |
26,239
-74,328
| -74% | -$550K | ﹤0.01% | 4876 |
|
|
2014
Q4 | $690K | Sell |
100,567
-7,106
| -7% | -$44.4K | ﹤0.01% | 4350 |
|
|
2014
Q3 | $581K | Buy |
107,673
+6,411
| +6% | +$37.4K | ﹤0.01% | 4448 |
|
|
2014
Q2 | $645K | Sell |
101,262
-22,167
| -18% | -$152K | ﹤0.01% | 4388 |
|
|
2014
Q1 | $995K | Sell |
123,429
-34,196
| -22% | -$266K | ﹤0.01% | 3913 |
|
|
2013
Q4 | $1.08M | Sell |
157,625
-141,016
| -47% | -$761K | ﹤0.01% | 3990 |
|
|
2013
Q3 | $5.5M | Buy |
298,641
+45,711
| +18% | +$888K | ﹤0.01% | 2319 |
|
|
2013
Q2 | $4.42M | Buy |
+252,930
| New | +$4.48M | ﹤0.01% | 2397 |
|
Other funds holding ARIA
Bank of America's ARIA Position: Q1 2017 in Review
Bank of America sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 67,923 shares — an estimated $846K sold.
Bank of America first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $5.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Bank of America reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Bank of America sold 67,923 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $846K.
- Bank of America first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Bank of America's Ariad Pharmaceuticals Inc position peaked at $5.5M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.